| Serial Number | 87660522 |
| Word Mark | GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT |
| Filing Date | Thursday, October 26, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 22, 2021 |
| Registration Number | 6396881 |
| Registration Date | Tuesday, June 22, 2021 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 17, 2020 |
| Description of Mark | The mark consists of the wording "GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT" and a design. The letters "G" and "D" are depicted inside a bisected oblong shape representing a pill. The letter "G" is in white with an outline in various shades of red. The letter "D" is in white with an outline in various shades of grey. The left half of the pill design with the letter "G" is in various shades of red. The right side of the pill design with the letter "D" is in various shades of grey. The number "3" is depicted in red with a white outline inside a stylized depiction of a molecule located to the upper right of the "GD" lettering. The molecule consists of four gold spheres representing atoms, which are connected by three straight bands in various shades of grey representing bonds. The stylized wording "GENESIS" appears in red below the "GD" lettering and pill design. The stylized wording "DRUG DISCOVERY & DEVELOPMENT" appears in smaller black font below the wording "GENESIS". |
| NOT AVAILABLE | "DRUG DISCOVERY & DEVELOPMENT" |
| Indication of Colors claimed | The color(s) red, black, white, gray and gold is/are claimed as a feature of the mark. |
| Goods and Services | Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery |
| Pseudo Mark | GD THREE GENESIS DRUG DISCOVERY AND DEVELOPMENT |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 4, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, November 30, 2016 |
| First Use In Commerce Date | Wednesday, November 30, 2016 |
| Party Name | Genesis Drug Discovery & Development, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Hamilton, NJ 08690 US |
| Party Name | Genesis Drug Discovery & Development, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Hamilton, NJ 08690 US |
| Party Name | Genesis Drug Discovery & Development, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Hamilton, NJ 08690 US |
| Event Date | Event Description |
| Monday, October 30, 2017 | NEW APPLICATION ENTERED |
| Saturday, November 4, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 7, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, February 6, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, February 21, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 21, 2018 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 21, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 17, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 17, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 18, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 6, 2018 | SUSPENSION LETTER WRITTEN |
| Thursday, September 6, 2018 | LETTER OF SUSPENSION E-MAILED |
| Thursday, September 6, 2018 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 26, 2019 | ASSIGNED TO LIE |
| Thursday, March 28, 2019 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, October 10, 2019 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Friday, November 1, 2019 | FINAL REFUSAL WRITTEN |
| Friday, November 1, 2019 | FINAL REFUSAL E-MAILED |
| Friday, November 1, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, January 14, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, January 14, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, February 3, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, February 3, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 4, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 10, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 26, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 17, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 17, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 12, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, October 16, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Saturday, October 31, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, October 16, 2020 | USE AMENDMENT FILED |
| Saturday, October 31, 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, November 2, 2020 | SU - NON-FINAL ACTION - WRITTEN |
| Monday, November 2, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, November 2, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 21, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 28, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 28, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 30, 2021 | ASSIGNED TO EXAMINER |
| Monday, May 17, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, May 18, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, June 22, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Friday, September 15, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, September 15, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, September 15, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, September 15, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, June 22, 2026 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |